Nuvation Bio Inc. (NUVB) Revenue History
Annual and quarterly revenue from 2018 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
NUVB Revenue Growth
Revenue Breakdown (FY 2025)
NUVB's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
NUVB Revenue Analysis (2018–2025)
As of May 8, 2026, Nuvation Bio Inc. (NUVB) generated trailing twelve-month (TTM) revenue of $143.0 million, reflecting explosive growth of +2598.7% year-over-year. The most recent quarter (Q1 2026) recorded $83.2 million in revenue, up 98.8% sequentially.
Looking at the longer-term picture, NUVB's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $62.9 million in 2025, representing a new all-time high.
Revenue diversification analysis shows NUVB's business is primarily driven by License (61%), and Product (39%). With over half of revenue concentrated in License, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including KYMR (-12.6% YoY), and AUPH (+20.4% YoY), NUVB has outperformed the peer group in terms of revenue growth. Compare NUVB vs KYMR →
NUVB Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| NUVBCurrent | $143M | +2598.7% | - | -338.7% | |
 KYMR | $39M | -12.6% | +2.9% | -891.3% | |
 AUPH | $283M | +20.4% | +41.4% | 37.1% |
NUVB Historical Revenue Data (2018–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $62.9M | +699.0% | $54.5M | 86.6% | $-213,064,000 | -338.7% |
| 2024 | $7.9M | - | $795K | 10.1% | $-592,627,000 | -7527.3% |
| 2023 | $0 | - | $0 | - | $-99,822,000 | - |
| 2022 | $0 | - | $0 | - | $-119,734,000 | - |
| 2021 | $0 | - | $0 | - | $-93,318,000 | - |
| 2020 | $0 | - | $-103,000 | - | $-43,551,000 | - |
| 2019 | $0 | - | $0 | - | $-32,098,999 | - |
| 2018 | $0 | - | $0 | - | $-992,000 | - |
See NUVB's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NUVB Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare NUVB vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonNUVB — Frequently Asked Questions
Quick answers to the most common questions about buying NUVB stock.
Is NUVB's revenue growth accelerating or slowing?
NUVB revenue is accelerating at +2598.7% year-over-year, exceeding the 5-year CAGR of N/A. TTM revenue reached $143M. Growth momentum has increased versus prior periods.
What is NUVB's long-term revenue growth rate?
Nuvation Bio Inc.'s 5-year revenue CAGR of N/A reflects the sustained expansion pattern. Current YoY growth of +2598.7% is above this long-term average.
How is NUVB's revenue distributed by segment?
NUVB reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2018-2025 are available for download. Segment mix reveals concentration and diversification trends.